F864-0133 Screening compound: 1-{5-[(4-fluorophenyl)carbamoyl]-1,3,4-thiadiazole-2-carbonyl}-N-[(furan-2-yl)methyl]piperidine-3-carboxamide

F864-0133 Screening compound: 1-{5-[(4-fluorophenyl)carbamoyl]-1,3,4-thiadiazole-2-carbonyl}-N-[(furan-2-yl)methyl]piperidine-3-carboxamide
F864-0133 Screening compound: 1-{5-[(4-fluorophenyl)carbamoyl]-1,3,4-thiadiazole-2-carbonyl}-N-[(furan-2-yl)methyl]piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F864-0133
1-{5-[(4-fluorophenyl)carbamoyl]-1,3,4-thiadiazole-2-carbonyl}-N-[(furan-2-yl)methyl]piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F864-0133

Molecular Formula

C21H20FN5O4S (C21 H20 FN5 O4 S)

Compound Name

1-{5-[(4-fluorophenyl)carbamoyl]-1,3,4-thiadiazole-2-carbonyl}-N-[(furan-2-yl)methyl]piperidine-3-carboxamide

IUPAC name

1-{5-[(4-fluorophenyl)carbamoyl]-134-thiadiazole-2-carbonyl}-N-[(furan-2-yl)methyl]piperidine-3-carboxamide

SMILES

O=C(C(CCC1)CN1C(c1nnc(C(Nc(cc2)ccc2F)=O)s1)=O)NCc1ccco1

InChI

InChI=1S/C21H20FN5O4S/c22-14-5-7-15(8-6-14)24-18(29)19-25-26-20(32-19)21(30)27-9-1-3-13(12-27)17(28)23-11-16-4-2-10-31-16/h2,4-8,10,13H,1,3,9,11-12H2,(H,23,28)(H,24,29)/t13-/m0/s1

InChI Key

NEROXICXSLSBER-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD14968802

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.49

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.143

Distribution Coefficient, logD

2.098

Water Solubility, LogSw

-2.70

Polar Surface Area

95.578

Acid Dissociation Constant (pKa)

8.37

Base Dissociation Constant (pKb)

-2.02

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.60

F864-0133 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Others
  • Phosphatases
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with F864-0133 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F864-0133?
Check Price and Availability of F864-0133, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F864-0133 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F864-0133
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F864-0133
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F864-0133 available by request